H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 69186
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 37169
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 24101
 
  
 
C07D HETEROCYCLIC COMPOUNDS 23139
 
  
 
C07K PEPTIDES 16120
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 14226
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 10157
 
  
 
G06T IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 9126
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 887
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 8439

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0073,078 RNF41 AS A BIOMARKER PREDICTING RESPONSE TO LENALIDOMIDE IN NON-DEL(5Q) MDSAug 21, 17Mar 15, 18[A61K, C12Q, G01N]
2018/0050,011 INFLAMMASOME ACTIVATION IN MYELODYSPLASTIC SYNDROMESFeb 26, 16Feb 22, 18[A61K, C12N]
2018/0014,866 BONE FUSION SYSTEMSep 28, 17Jan 18, 18[A61F, A61B]
2017/0367,653 ENDOTRACHEAL TUBES AND SYSTEMS AND METHODS FOR EVALUATING BREATHINGMar 13, 15Dec 28, 17[A61B, A61M]
2017/0340,284 ARTERIAL CATHETERS AND METHODS OF USENov 02, 15Nov 30, 17[A61B, A61M]
2017/0333,565 TLR9 TARGETED CYTOTOXIC AGENTSOct 30, 15Nov 23, 17[A61K, C12N, G01N]
2017/0335,009 TETRAVALENT TLR9 BISPECIFIC ANTIBODYOct 30, 15Nov 23, 17[A61K, C07K]
2017/0335,403 METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL TUMORSNov 10, 15Nov 23, 17[C12Q]
2017/0299,599 PHOSPHORYLATION OF HISTONES AND USES THEREOFMar 13, 17Oct 19, 17[C12Q, G01N, C07K]
2017/0209,602 METHOD AND COMPOSITIONS FOR ORALLY ADMINISTERED CONTRAST AGENTS FOR MR IMAGINGMay 11, 15Jul 27, 17[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9878999 Proteasome chymotrypsin-like inhibition using PI-1833 analogsSep 24, 13Jan 30, 18[A61K, C07D]
9868747 Marinopyrrole derivatives and methods of making and using sameFeb 18, 15Jan 16, 18[A61K, A01N, C07F, C07D, A61N]
9863935 Predictive biomarkers for CTLA-4 blockade therapy and for PD-1 blockade therapyMar 15, 13Jan 09, 18[A61K, G01N, C07K]
9850216 Inhibitors of ACK1/TNK2 tyrosine kinaseAug 06, 14Dec 26, 17[C07D, C07C]
9820788 Bone fusion systemOct 05, 12Nov 21, 17[A61F, A61B]
9822135 STAT3 dimerization inhibitorsOct 30, 13Nov 21, 17[A61K, C07F, C07D, C07C]
9808447 Inhibitors of Rho associated protein kinases (ROCK) and methods of useAug 08, 16Nov 07, 17[A61K, C07D, A61N]
9809858 O-glycan pathway ovarian cancer signatureApr 05, 13Nov 07, 17[C12Q, G01N]
9804160 Protein-protein interaction as biomarkersSep 27, 12Oct 31, 17[G01N]
9770513 Method of developing a vaccine using peptide-poly IC complexesOct 08, 13Sep 26, 17[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0200,804 COMPOSITIONS AND METHODS FOR TREATING ANAPLASTIC THYROID CANCERAbandonedJan 11, 16Jul 14, 16[A61K, C12N, C07K]
2016/0051,704 MOLECULAR IMAGING PROBES FOR LUNG CANCER INTRAOPERATIVE GUIDANCEAbandonedNov 10, 15Feb 25, 16[A61K]
2015/0302,140 IN SILICO IDENTIFICATION OF CANCER MOLECULAR SIGNALING PATHWAYS AND DRUG CANDIDATESAbandonedNov 04, 13Oct 22, 15[G06F]
2015/0125,858 DETERMINING PROSTATE CANCER RECURRENCE USING POLYMORPHISMS IN ANGIOGENESIS-RELATED GENESAbandonedMay 09, 13May 07, 15[C12Q]
2015/0105,328 PEPTOID-PEPTIDE HYBRIDS AND THEIR USEAbandonedDec 18, 14Apr 16, 15[A61K, G01N, C07K]
2014/0322,227 PEPTIDES FOR TREATMENT OF BONE DEFICIENCY AND AUTOIMMUNE DISORDERSAbandonedApr 28, 14Oct 30, 14[A61K, C07K]
2014/0309,476 CT ATLAS OF MUSCULOSKELETAL ANATOMY TO GUIDE TREATMENT OF SARCOMAAbandonedJun 25, 14Oct 16, 14[A61N]
2014/0109,903 OROGASTRIC TUBE GUIDES AND METHODS OF USING THE SAMEAbandonedApr 20, 12Apr 24, 14[A61J, A61M]
2014/0080,762 HYD1 PEPTIDES FOR RELAPSED CANCERAbandonedMar 21, 12Mar 20, 14[A61K, G01N, C07K]
2014/0045,883 ACK1 KINASE INHIBITION TO TREAT TRIPLE NEGATIVE BREAST CANCERAbandonedAug 12, 13Feb 13, 14[A61K, G01N]
2014/0047,570 ANIMAL MODEL OF HUMAN CANCER AND METHODS OF USEAbandonedApr 19, 12Feb 13, 14[A61K]
2014/0031,251 METHODS OF CLASSIFYING HUMAN SUBJECTS WITH REGARD TO CANCER PROGNOSISAbandonedNov 02, 11Jan 30, 14[C12Q]
2013/0304,028 CATHETER CLAMPS AND CATHETERSAbandonedFeb 03, 12Nov 14, 13[A61M]
2013/0295,185 COMPOUNDS AND METHODS FOR INDUCING APOPTOSIS IN CANCER CELLS USING A BH3 ALPHA-HELICAL MIMETICAbandonedJul 12, 13Nov 07, 13[A61K, C07C]
2013/0251,752 CHEMOKINE GENE-MODIFIED CELLS FOR CANCER IMMUNOTHERAPYAbandonedMay 13, 13Sep 26, 13[A61K]
2013/0252,831 METHOD OF DIAGNOSING EARLY STAGE NON-SMALL CELL LUNG CANCERAbandonedMay 10, 13Sep 26, 13[C12N]
2013/0059,015 Human Cancer micro-RNA Expression Profiles Predictive of Chemo-ResponseAbandonedMar 11, 11Mar 07, 13[A61K, C12Q, C12N, A61P, C40B]
2013/0018,215 ESOPHAGEAL STENT AND METHODS FOR USE OF SAMEAbandonedJan 18, 12Jan 17, 13[A61F, A61N]
2012/0215,158 ENDOSCOPIC CAPS FOR IONIZED PLASMA CONFINEMENT, SHAPING AND CONTROL OF THERAPEUTIC PURPOSESAbandonedAug 20, 10Aug 23, 12[A61M]
2012/0155,732 CT Atlas of Musculoskeletal Anatomy to Guide Treatment of SarcomaAbandonedDec 23, 11Jun 21, 12[G06K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.